Injectable Drug Delivery 2019

May 15-16, 2019 | UK

SMi Group’s second annual Injectable Drug Delivery conference offers regulatory, device design, packaging, and formulation professionals a chance to learn about innovative injectable drug delivery systems with industrial insights.

Spotlight

Once the industry has normalized after a turbulent 2020,
life sciences leaders can still count on continued change.
The future will be challenging at best without the support
of next-gen BI as life sciences navigate their businesses
through new or growing competition, economic recovery,
regulatory and political pressures, barriers to market access,
and an increased demand for personalized medicine.


OTHER PAST CONFERENCES

Virtual PharmaSynergy

February 23-24, 2023 | USA

The event is designed for the BD&Licensing pharma professionals focusing on generics and value-added products

International Meet on Pharmaceutics and Drug Delivery Systems

February 9-11, 2023 | Portugal

It is our pleasure to invite all scientists, academicians, young researchers, business delegates and students from all over the world to attend the International Meet on Pharmaceutics and Drug Delivery Systems will be held in Porto, Portugal during February 09-11, 2023.

7th Microbiome Movement - Drug Development Summit Europe

January 31-February 2, 2023 | UK

The 7th Microbiome Movement - Drug Development Summit Europe will unite Europe’s leading drug developers and microbiome experts to share their latest discoveries on microbiome functionality, translation, clinical development, biomarker discovery and manufacturing scale-up.

2023 ISPE Facilities of the Future Conference

January 31-February 1, 2023 | USA

The 2023 ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future.

Spotlight

Once the industry has normalized after a turbulent 2020,
life sciences leaders can still count on continued change.
The future will be challenging at best without the support
of next-gen BI as life sciences navigate their businesses
through new or growing competition, economic recovery,
regulatory and political pressures, barriers to market access,
and an increased demand for personalized medicine.

resources